Infantile fibrosarcoma: Is spontaneous regression possible?-Reference-Cited by-同舟云学术

Infantile fibrosarcoma: Is spontaneous regression possible?

Published:2023-08-14 Issue:11 Volume:70 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Orbach Daniel¹^ORCID,Sparber‐Sauer Monika²,Corradini Nadege³,Ferrari Andrea⁴^ORCID,Owens Cormac⁵,Casanova Michela⁴

Affiliation:

1. SIREDO Oncology Center (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), PSL University Institut Curie Paris France

2. Klinikum der Landeshauptstadt Stuttgart gKAöR, Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder‐, Jugend‐ und Frauenmedizin, Pädiatrie 5 (Pädiatrische Onkologie, Hämatologie, Immunologie), Stuttgart, Germany Medizinische Fakultät der Universität Tübingen Tübingen Germany

3. Department of Pediatric Oncology, Institut d'Hematologie et d'Oncologie Pédiatrique Centre Léon Bérard Lyon France

4. Department of Oncology Pediatric Oncology Unit Fondazione IRCCS Istituto Nazionale Tumori Milan Italy

5. Department of Oncology Children's Health Ireland at Crumlin Dublin Ireland

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.30623

Reference16 articles.

1. Infant cancers in France: Incidence and survival (2000–2014)

2. Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: International consensus and remaining controversies

3. Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experience

4. The impact of local control in the treatment of children with advanced infantile and adult-type fibrosarcoma: Experience of the cooperative weichteilsarkom studiengruppe (CWS)

5. Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysis